169 related articles for article (PubMed ID: 18203843)
1. Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases.
Pacher P; Ungvári Z
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1133-4. PubMed ID: 18203843
[No Abstract] [Full Text] [Related]
2. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.
Jiang S; Fu Y; Williams J; Wood J; Pandarinathan L; Avraham S; Makriyannis A; Avraham S; Avraham HK
PLoS One; 2007 Jul; 2(7):e641. PubMed ID: 17653268
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoid signalling as an anti-inflammatory therapeutic target in atherosclerosis: does it work?
Immenschuh S
Cardiovasc Res; 2009 Dec; 84(3):341-2. PubMed ID: 19819883
[No Abstract] [Full Text] [Related]
4. [Endocannabinoid system and bowel inflammation].
Márquez L; Abanades S; Andreu M
Med Clin (Barc); 2008 Oct; 131(13):513-7. PubMed ID: 19007582
[TBL] [Abstract][Full Text] [Related]
5. Role of cannabinoid CB2 receptors in glucose homeostasis in rats.
Bermudez-Silva FJ; Sanchez-Vera I; Suárez J; Serrano A; Fuentes E; Juan-Pico P; Nadal A; Rodríguez de Fonseca F
Eur J Pharmacol; 2007 Jun; 565(1-3):207-11. PubMed ID: 17499236
[TBL] [Abstract][Full Text] [Related]
6. [The cannabinoid system and pain: towards new drugs?].
Beltramo M
J Soc Biol; 2009; 203(1):99-106. PubMed ID: 19358815
[TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
Fride E
Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
[TBL] [Abstract][Full Text] [Related]
8. Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.
Pandey R; Hegde VL; Singh NP; Hofseth L; Singh U; Ray S; Nagarkatti M; Nagarkatti PS
Vitam Horm; 2009; 81():487-504. PubMed ID: 19647124
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid 1 (CB1) receptor--pharmacology, role in pain and recent developments in emerging CB1 agonists.
Talwar R; Potluri VK
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):536-44. PubMed ID: 21631407
[TBL] [Abstract][Full Text] [Related]
10. The Important Role of the Endocannabinoid System and the Endocannabinoidome in Gut Health.
Meletis C
Altern Ther Health Med; 2019 Jun; 25(S2):24-28. PubMed ID: 31202201
[TBL] [Abstract][Full Text] [Related]
11. CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.
Rajesh M; Mukhopadhyay P; Bátkai S; Haskó G; Liaudet L; Huffman JW; Csiszar A; Ungvari Z; Mackie K; Chatterjee S; Pacher P
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2210-8. PubMed ID: 17660390
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation.
Wright KL; Duncan M; Sharkey KA
Br J Pharmacol; 2008 Jan; 153(2):263-70. PubMed ID: 17906675
[TBL] [Abstract][Full Text] [Related]
13. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
Klegeris A; Bissonnette CJ; McGeer PL
Br J Pharmacol; 2003 Jun; 139(4):775-86. PubMed ID: 12813001
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid mechanisms of pain suppression.
Walker JM; Hohmann AG
Handb Exp Pharmacol; 2005; (168):509-54. PubMed ID: 16596786
[TBL] [Abstract][Full Text] [Related]
15. [Endocannabinoids: therapeutic perspectives in chronic liver diseases].
Lotersztajn S; Teixeira-Clerc F; Hezode C; Tran van Nhieu J; Deveaux V; Mallat A
Gastroenterol Clin Biol; 2007 Mar; 31(3):255-8. PubMed ID: 17396081
[No Abstract] [Full Text] [Related]
16. 2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2.
Kaplan BL; Ouyang Y; Rockwell CE; Rao GK; Kaminski NE
J Leukoc Biol; 2005 Jun; 77(6):966-74. PubMed ID: 15774549
[TBL] [Abstract][Full Text] [Related]
17. Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor.
Taylor L; Christou I; Kapellos TS; Buchan A; Brodermann MH; Gianella-Borradori M; Russell A; Iqbal AJ; Greaves DR
Sci Rep; 2015 Jun; 5():10682. PubMed ID: 26033291
[TBL] [Abstract][Full Text] [Related]
18. CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration.
Rajesh M; Mukhopadhyay P; Haskó G; Huffman JW; Mackie K; Pacher P
Br J Pharmacol; 2008 Jan; 153(2):347-57. PubMed ID: 17994109
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid Receptor 1 and 2 Signaling Pathways Involved in Sepsis.
Leite-Avalca MCG; Zampronio A; Lehmann C
Shock; 2021 Nov; 56(5):673-681. PubMed ID: 33625115
[TBL] [Abstract][Full Text] [Related]
20. CB2 receptor-mediated migration of immune cells: it can go either way.
Miller AM; Stella N
Br J Pharmacol; 2008 Jan; 153(2):299-308. PubMed ID: 17982478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
